TQ Therapeutics raises €5.3M Seed round
15 January 2024· Martinsried, Germany· health, biotech, robotics, b2b, software_hardware
The funding is dedicated to the development of a transformative, modular, and automated bedside cell processing platform for ultra-short extracorporeal cell and gene therapy (CGT), moving production from centralized facilities to on-site processing.
Investors
LeadHigh-Tech Gründerfonds
Also participating
Bristol-Myers SquibbVentura BioMed InvestorsJuno Therapeutics
About TQ Therapeutics
Stage
Seed
Headquarters
Martinsried, Germany
Founded
2023
Team Size
6–20
Sectors
healthbiotechroboticsb2bsoftware_hardware